Clinical Trial Update: WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating whether a lower dose of aspirin after acute coronary syndrome may be more effective.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED